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Background: Arteriovenous fistulae (AVF) are preferred for dialysis access but require accurate 
cannulation for effective dialysis. Evidence supports improvements in cannulation and 
complication rates using ultrasound guidance (USG) in cannulating other sites. This mixed 
methods, randomised controlled trial aimed to assess effects of USG during AVF cannulation. 
 
Methods: Participants with difficult to cannulate AVF had each cannulation event randomised to 
USG or standard technique (no USG). The primary outcome was the incidence and number of 
additional needle passes. Secondary outcomes included: the incidence and number of additional 
skin punctures; time to achieve two needle cannulation; pain associated with cannulation; local 
complications. Qualitative outcomes were assessed using patient and staff questionnaires. 
 
Results: 32 participants had 346 cannulation events randomised (170 to USG and 176 to standard 
cannulation). USG resulted in a significant reduction in additional needle passes (72 vs 99 
p=0.007) and additional skin punctures (10 vs 25 p=0.016.) but prolonged time to cannulation 
(p>0.001). There was no difference in pain score (p=0.705) or complications between groups. 
Questionnaires demonstrated that USG cannulation is acceptable to patients and staff.  
 
Conclusion: USG cannulation of AVF is more accurate and no more painful than non-image 
guided cannulation, but prolonged time to cannulation. Some of the excess time involved may be 
due to the trial being performed early in cannulating staff’s learning curve with the USG 
technique. Further work to elucidate which patients gain most benefit from USG cannulation and 





Autologous arteriovenous fistulae (AVF) are the gold-standard haemodialysis access, associated 
with reduced morbidity and mortality compared to other forms of dialysis access (1) With 
increasing AVF prevalence as well as aging and more obese populations in the developed world, 
increasing numbers of difficult-to-cannulate AVFs are being encountered in practice (​1,​2,3). 
AVFs that require multiple needling attempts may suffer more frequent complications which can 
require prolonged central catheter use or even cause AVF failure resulting in patient 
dissatisfaction, increased interventions and higher costs. (3,4,5).  
There is good evidence that ultrasound guidance (USG) significantly increases successful 
cannulation rates in central venous (6,7) and peripheral vessel access (8,9). Additionally, there 
have been increasing reports of the use of US for difficult fistulae access (3,10,11).  USG is 
currently recommended by the Canadian Association of Nephrology Nurses and Technologists’ 
recommendations for the management of vascular access (12), with evidence that ‘blind’ 
cannulation results in suboptimal needle placement and potential AVF complications (13) 
 We hypothesised that USG cannulation of fistulae would improve accuracy of cannulation of 




To investigate whether USG cannulation improves cannulation accuracy, time to completion of 
of two needle cannulation, and reduces complication rates in difficult fistulae.  
 
Methods: 
A prospective non-blinded randomised controlled trial was performed comparing the use of USG 
for the cannulation of difficult to access AVF compared to standard practice (non-USG). Full 
UK research ethics committee approval was obtained prior to study commencement and the 
protocol was prospectively registered with ​ClinicalTrials.gov - identifier: NCT01163981. 
 
Many units stratify AVF according to the level difficulty of their needling to ensure that the most 
difficult fistulae are cannulated by the most experienced staff. Stratification criteria are based on 
a variety of factors including the maturity of the fistulae, history of complications or thrombosis, 
difficulty of palpation and patient anxiety. In our unit, AVF are regularly stratified  according to 
a “traffic light” system (Table 1) by the vascular access co-ordinator. This stratification ensures 
appropriate staff are available to cannulate each patient.  
 
Patients​ were recruited from the current population receiving dialysis in a University Teaching 
Hospital dialysis unit.  Inclusion criteria included: Patients over 18 years with a difficult to 
cannulate AVF (amber, red or black) (Table 1) who dialyse three times weekly via two needles; 
ability to provide informed consent. Exclusion criteria included: deviation from routine dialysis 
protocol; active or recent (within 2 weeks) AVF complications. ​Accurate AVF stratification was 
confirmed by the ​vascular access nurse specialist prior to recruitment. Depth of the AVF wall 
from the skin surface was measured at 4 points along the needled length of the fistula at the time 
of consent by a Ultrasound competent investigator.  
 
Staff training​ was commenced 2 months prior to patient recruitment. A training package was 
developed by a senior vascular surgeon and two investigators trained in US guided cannulation 
for delivery to dialysis unit staff. Delivered training consisted of two theory sessions covering 
use of sonosite portable US machines, followed by two practical teaching sessions with low 
fidelity models (branched 2 vessel training block, ​Blue phantom USA​) favouring the transverse 
imaging cannulation technique. Assessment of cannulation technique using models was then 
conducted, with each member of staff having to cannulate low-fidelity model vessels of 5mm 
diameter at 20mm depth accurately and independently at least three times before they were 
allowed to perform the task supervised on patients. Training in consenting dialysis patients was 
practised for cannulation of difficult AVF with US guidance under investigator supervision by 
each member of cannulation staff over four weeks prior to trial commencement.  
 
Randomisation​: Following informed written consent, participants had each dialysis cannulation 
event over the subsequent four weeks randomised to either the USG or standard (non-USG) 
technique. Both interventions were undertaken by an appropriately trained member of staff. A 
randomisation list was produced via an online generator (​www.randomization.com​) and placed 
in sequentially numbered sealed opaque envelopes. Envelopes were opened by investigators 
immediately prior to cannulation and neither cannulation staff nor the patients were aware of 
allocation prior to the cannulation event. Due to the nature of the intervention over a prolonged 
period in an open plan unit, blinding was not possible. We were able to reduce confounding 
factors such as BMI, staff aptitude for a particular skill, patient tolerance and fistula 
characteristics by randomising cannulation events rather than patients. 
 
Interventions​: ​USG cannulation was performed using an aseptic transverse ultrasound technique 
with the Sonosite Edge II ultrasound system (Fujifilm Sonosite, Washington, USA). The 
HFL50X Sonosite straight probe was used with no preset, the use of simple ultrasound with a 
straight probe making the intervention generalisable to dialysis units around the globe. Sterile 
probe covers and gel were used for USG cannulations, and standard drape covers used for all 
procedures as per normal policy in our unit. The standard or control (non-USG) cannulations 
were performed using vision and palpation to guide the placement of needles. ‘Wet’ cannulation, 
using needles pre-flushed with normal saline is standard practice in our unit. Every cannulation 
event was observed and timed by one of two investigators to ensure accurate recording of 
outcomes and times. Time recording was started from the time of placing the probe on the fistula 
for USG cannulations and time of the fingers touching the fistula for control cannulations. 
Completed cannulation and stopping of timing was once  blood ‘flash back’ was checked in both 
arterial and venous needles ready for dialysis. Ropeladder cannulation technique is used as 
standard practice in our unit.  
Outcomes​: Primary outcome was the incidence and number of additional needle passes required 
for successful needle placement. Additional needle passes were defined as needle pull back and 
change in direction of the needle following skin puncture, without withdrawal from the skin / 
additional skin punctures. This was chosen as there is some evidence that increased passes of the 
needle correlate with fistula complications (14). 
Secondary outcomes assessed at each cannulation event included: 
The incidence and number of additional skin punctures required, defined as full withdrawal of 
the needle from the skin necessitating further passage of the needle through the skin. 
Time in seconds to achieve two needle cannulation, defined as the time from first skin puncture 
to successful flushing of the second needle. 
Patient reported pain associated with cannulation, recorded on a 10cm visual analogue scale 
scored from 1 (no pain) to 10 (worst pain imaginable), as well as difficulty in cannulation as 
recorded by staff, scored from 1 (minimal difficulty) to 10 (extremely difficult.) 
Local complications (e.g. bleeding, vessel and needle thrombosis) relating to the individual 
cannulation event were also recorded. 
Patient Questionnaires: were completed by patients at recruitment, halfway through the trial 
period and at trial conclusion. Questions related to cannulation discomfort and anxiety prior to 
cannulation, measured on an ordinal scale from ‘​Not at all’​ to ​‘Extreme.’ ​Additionally, questions 
related to overall fistula satisfaction and acceptability of USG to patients.  
Staff questionnaires: were completed by staff responsible for cannulation of participants within 
the trial following trial completion. Question related to the perceptions of USG in AVF 
cannulation.  
A convenience sample of 30-35 consenting patients each having 12 cannulations was used based 
upon the suitable patients dialysing in the unit at the time of the trial and investigator resources 
available to complete the study. Each visit was randomised to cannulation either using USG or 
standard practice.  
Data analysis was performed using SPSS (version 22, IBM, New York, USA). Needle passes and 
skin puncture outcomes were analysed as binary outcomes (those requiring only 2 punctures or 
passes and those requiring additional punctures or passes). For pain and difficulty scores, we 
examined those above and below the mean. Pearson Chi-squared and Mann-Whitney U 
non-parametric tests were used to determine significance depending on the distribution of data. 
Levene’s test was used to test homogeneity. A comparison of results between stratification of 
AVF was made to determine the relative benefits of USG with different levels of expected 
cannulation difficulty. Similarly, maximum and minimum fistula depth were averaged and split 
into two groups around the mean, for rating of the benefits of USG for fistula at greater depth.  
 
Results 
Patients: 48 of 185 screened patients on the dialysis unit were identified as dialysing with an 
AVF stratified as either ‘amber,’ ‘red’ and ‘black’. Thirty seven patients met all eligibility 
criteria and were invited to participate in the study, and 32 patients subsequently consented to 
participate. One participant withdrew after 7 cannulations due to dissatisfaction with the 
ultrasound technique, and 3 participants were transferred to satellite dialysis units during the 
study period (figure 1), resulting in 346 cannulation events being randomised; 170 events to 
USG cannulation and 176 events to standard (non-USG) cannulation. 
Baseline demographics were collected for patients, including age, BMI and co-morbidities at 
time of consent. These are reported alongside recent UK national audits for renal vascular access 
in Table 2 (15).  
 
Overall Results are summarised in Table 3.  
Primary Outcome 
USG cannulation resulted in a significant reduction in the incidence of additional (72 ​vs 
99)(​p=0.007​) and absolute number (mean 2.74 ​vs​ 3.77)(p=<0.001) of needle passes (Table 3)  
Secondary outcomes 
USG cannulation resulted in a significant reduction in the incidence of additional (10 ​vs 
25)(​p=0.016​) and absolute number (mean 2.06 ​vs​ 2.17)(p=0.015) of skin punctures. 
USG cannulation resulted in a significant increase in the time to achieve two needle cannulation 
(median 190sec vs 118sec)(p= <0.001). Mean time to cannulation in the USG events is indicated 
in figure 2 and was seen to significantly improved by over a minute when comparing the first 
and last quartiles of the recruitment period (p=0.013). 
Patient reported pain associated with cannulation was not significantly different between the 
USG cannulation and the standard (no USG) group. Lidocaine injections or topical anaesthetic 
creams were used as per patient preference as is normal on our unit. No changes to patients usual 
anaesthetic regime was made for either USG and non-USG cannulations and there was  no 
significant difference in their use between events (p=0.802.) 
There were no significant differences in local complications between the 2 groups (Table 3). 
.Comparison of results between stratifications of AVF are shown in table 4, while results 
between fistula of different depths are shown in table 5. Results according to AVF stratification 
and fistula depth were post hoc exploratory analyses and were not predefined outcomes.  
 
Patient questionnaires 
There was no difference in levels of patient satisfaction with their fistula between baseline and 
trial exit (​p=0.98​), nor any difference in patient anxiety related to cannulation​ (p=0.87)​. 57% of 
recruited patients reported to experience ‘​A little bit’​ of discomfort. There was no difference in 
overall levels of discomfort reported by patients at baseline compared to trial exit or between US 
guided and control cannulation events. There was no significant association between anxiety and 
reported discomfort in the recruited patients​. 
Staff questionnaire 
Twenty two cannulating staff questionnaires were completed at the cessation of the trial.  Greater 
USG cannulation experience was correlated with improved confidence in the technique though 
this did not reach significance (p=0.059). 25% of staff felt that US guided cannulation was 
neither slower nor faster than the conventional method while 50% maintained that the US 
method took longer.  
Questionnaire data from nursing staff suggested that confidence increased with increased USG 
experience, and that staff with more USG experience were also noted to have a greater appetite 
for further training indicating that the technique was popular with staff. 85% of nurse 
respondents felt they would benefit from further cannulation experience. Those nurses with the 
highest levels of prior experience with non-image guided cannulation tended to report the least 
enthusiasm for further USG experience and additional training.  Apart from training offered by 
trial investigators, none of the cannulating staff involved in the trial had significant prior USG 
cannulation training, while limited numbers of senior nurses were in the practice of using US for 
basic fistula assessment in the event of complications. Prior non-USG  haemodialysis 
cannulation experience ranged from 6 months to 20 years. 
 
Discussion 
This prospective randomised trial of USG cannulation of difficult to cannulate fistulae has 
proven the feasibility of the technique for use in a busy tertiary outpatient haemodialysis unit. 
Previously, barriers to the use of ultrasound in dialysis access have included the requirement of 
skilled staff, logistical difficulties due to the high turnover of staff, time-pressured haemodialysis 
environment and cost ​(5​)​ ​We have demonstrated the effectiveness of introducing a short training 
programme for cannulating staff and shown that use of USG cannulation did not impact on 
patient anxiety or discomfort.  USG facilitated cannulation, reducing additional needle passes 
and skin punctures, though prolonged time taken for cannulation by approximately 60 seconds. It 
should be acknowledged that nurses were assisted by trial investigators in the setup of US 
including moving the US system and placing sterile probe covers prior to commencement of the 
timer.  The small increase in time to set up dialysis did not interfere with the running of the unit 
during this study and cannulation times improved significantly over the course of the trial (figure 
2), implying that the nurses were likely to still be relatively early in their learning curves for 
USG cannulation. As such, further improvements in speed of use and other outcomes might be 
expected with increased experience as was seen by a reduction in USG cannulation time during 
the trial period as above.  
Though numbers for analysis are small, an exploratory comparison of cannulations over the three 
grades of AVF included demonstrated that amber patients appeared to gain relatively limited 
benefit from use of ultrasound. Amber AVF showed a non-significant difference in the number 
of skin punctures or needle passes between US guided and control cannulations, whilst there was 
a marked increase in time taken (70 seconds longer). Benefits of US guidance were more 
pronounced in the more difficult red AVF showing highly significant reductions in needle passes 
and skin punctures with a much reduced disparity in time taken (only 10 seconds). The most 
difficult black fistulae might be expected to show the greatest level of benefit, though differences 
for accuracy were non-significant in this group and time to cannulation was significantly longer 
again (73 seconds longer on average). Explanations of this seemingly anomalous finding may be 
that some AVF were labelled as black solely due to being less than 3 months since old, and may 
in fact be readily palpable and easy to cannulate without imaging assistance. Equally, 
cannulation of black fistulae is reserved exclusively for those staff with the highest levels of 
experience so the standard cannulations of this group may be expected to be of the very highest 
standard.  
Breakdown of results by relative depth of a fistula appear to reinforce the idea that US guided 
cannulation has greater benefit in those fistula which are expected to be more difficult to 
cannulate. There were significantly reduced needle passes and skin punctures in USG 
cannulation of deeper fistulae, as well as reduced differences in time to cannulation (table 5.) 
 
Limitations 
This trial was a pragmatic design demonstrating that US can be quite quickly implemented in a 
busy haemodialysis outpatient unit without major disruption to the day to day running of the unit. 
Randomisation of cannulation event rather than participants was used to reduce the risk of 
selection or performance bias, as well as confounding factors. However due to the nature of the 
intervention, it was impossible to blind patients to the use of US. The learning curve for US 
guided cannulation may also have been underestimated prior to trial implementation and a 
measurable improvement in US performance seen during the trial would support this. It is 
conceivable that further training and experience may result in improved speed and other 
desirable outcomes. Further work could also elucidate whether familiarity with USG cannulation 
might allow cannulating staff to identify signs of fistula complications early, which could result 
in earlier intervention and improved fistula care or even survival. 
  
Patient and cannulation numbers in this study were relatively small and insufficient to detect 
observable improvements in complication rates, concentrating instead on outcomes of accuracy 
as a surrogate marker of  the risk of complications. As such, any future prospective studies may 
require a larger sample and longer follow-up in order to detect a reduction in complication rate or 
improved AVF patency. As USG becomes more widely practiced in dialysis centres, an 
important outcome measure for subsequent work will be cannulation site rotation. It is the belief 
of the investigators of this study that equipping nurses with ultrasound skills may give nurses 
confidence to cannulate additional areas of the AVF, helping reduce the practice of relative 
‘area’ cannulation and thus further reducing AVF complications.  
 
Conclusion 
This trial demonstrated that US guided cannulation can be introduced to a busy dialysis unit, and 
showed a significant benefit in terms of accuracy of cannulation for more difficult to cannulate 
patients. While cannulation times were slightly prolonged, there were no significant changes in 
patient reported pain, or staff reported difficulty. It is possible that this trial was conducted early 
in the cannulating staff’s learning curve as measurable and significant improvement in time to 
cannulation was seen, even over the short duration of this trial. Further analysis by AVF grading 
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